Matches in SemOpenAlex for { <https://semopenalex.org/work/W4368358565> ?p ?o ?g. }
- W4368358565 abstract "Abstract Background Bone metastasis is the leading cause of death in patients with prostate cancer (PCa) and currently has no effective treatment. Disseminated tumor cells in bone marrow often obtain new characteristics to cause therapy resistance and tumor recurrence. Thus, understanding the status of disseminated prostate cancer cells in bone marrow is crucial for developing a new treatment. Methods We analyzed the transcriptome of disseminated tumor cells from a single cell RNA-sequencing data of PCa bone metastases. We built a bone metastasis model through caudal artery injection of tumor cells, and sorted the tumor hybrid cells by flow cytometry. We performed multi-omics analysis, including transcriptomic, proteomic and phosphoproteomic analysis, to compare the difference between the tumor hybrid cells and parental cells. In vivo experiments were performed to analyze the tumor growth rate, metastatic and tumorigenic potential, drug and radiation sensitivity in hybrid cells. Single cell RNA-sequencing and CyTOF were performed to analyze the impact of hybrid cells on tumor microenvironment. Results Here, we identified a unique cluster of cancer cells in PCa bone metastases, which expressed myeloid cell markers and showed a significant change in pathways related to immune regulation and tumor progression. We found that cell fusion between disseminated tumor cells and bone marrow cells can be source of these myeloid-like tumor cells. Multi-omics showed the pathways related to cell adhesion and proliferation, such as focal adhesion, tight junction, DNA replication, and cell cycle, were most significantly changed in these hybrid cells. In vivo experiment showed hybrid cells had a significantly increased proliferative rate, and metastatic potential. Single cell RNA-sequencing and CyTOF showed tumor-associated neutrophils/monocytes/macrophages were highly enriched in hybrid cells-induced tumor microenvironment with a higher immunosuppressive capacity. Otherwise, the hybrid cells showed an enhanced EMT phenotype with higher tumorigenicity, and were resistant to docetaxel and ferroptosis, but sensitive to radiotherapy. Conclusion Taken together, our data demonstrate that spontaneous cell fusion in bone marrow can generate myeloid-like tumor hybrid cells that promote the progression of bone metastasis, and these unique population of disseminated tumor cells can provide a potential therapeutic target for PCa bone metastasis." @default.
- W4368358565 created "2023-05-05" @default.
- W4368358565 creator A5002318539 @default.
- W4368358565 creator A5016322661 @default.
- W4368358565 creator A5018406495 @default.
- W4368358565 creator A5024557025 @default.
- W4368358565 creator A5049277889 @default.
- W4368358565 creator A5057209439 @default.
- W4368358565 creator A5061440496 @default.
- W4368358565 creator A5078949281 @default.
- W4368358565 date "2023-05-03" @default.
- W4368358565 modified "2023-10-13" @default.
- W4368358565 title "Myeloid-like tumor hybrid cells in bone marrow promote progression of prostate cancer bone metastasis" @default.
- W4368358565 cites W1969837802 @default.
- W4368358565 cites W1971620413 @default.
- W4368358565 cites W1995692874 @default.
- W4368358565 cites W1997183854 @default.
- W4368358565 cites W2005334224 @default.
- W4368358565 cites W2006986876 @default.
- W4368358565 cites W2012471677 @default.
- W4368358565 cites W2020472510 @default.
- W4368358565 cites W2027941483 @default.
- W4368358565 cites W2027988626 @default.
- W4368358565 cites W2031735540 @default.
- W4368358565 cites W2083158919 @default.
- W4368358565 cites W2111146828 @default.
- W4368358565 cites W2119764457 @default.
- W4368358565 cites W2136818856 @default.
- W4368358565 cites W2157756773 @default.
- W4368358565 cites W2396599501 @default.
- W4368358565 cites W2521381098 @default.
- W4368358565 cites W2606001457 @default.
- W4368358565 cites W2727380696 @default.
- W4368358565 cites W2739067554 @default.
- W4368358565 cites W2786843484 @default.
- W4368358565 cites W2786987313 @default.
- W4368358565 cites W2884834674 @default.
- W4368358565 cites W2891595642 @default.
- W4368358565 cites W2894506306 @default.
- W4368358565 cites W2906067435 @default.
- W4368358565 cites W2907794898 @default.
- W4368358565 cites W2911631458 @default.
- W4368358565 cites W2912991678 @default.
- W4368358565 cites W2923394609 @default.
- W4368358565 cites W2947513865 @default.
- W4368358565 cites W2950996070 @default.
- W4368358565 cites W2968190332 @default.
- W4368358565 cites W2983881420 @default.
- W4368358565 cites W2990035987 @default.
- W4368358565 cites W2990125601 @default.
- W4368358565 cites W2998931275 @default.
- W4368358565 cites W3016044799 @default.
- W4368358565 cites W3024126283 @default.
- W4368358565 cites W3034194107 @default.
- W4368358565 cites W3111328976 @default.
- W4368358565 cites W3116510596 @default.
- W4368358565 cites W3121718037 @default.
- W4368358565 cites W3122995267 @default.
- W4368358565 cites W3124284550 @default.
- W4368358565 cites W3124890479 @default.
- W4368358565 cites W3126490923 @default.
- W4368358565 cites W3128646645 @default.
- W4368358565 cites W3129159017 @default.
- W4368358565 cites W3153299698 @default.
- W4368358565 cites W3158921021 @default.
- W4368358565 cites W3159454489 @default.
- W4368358565 cites W3160005431 @default.
- W4368358565 cites W3168457900 @default.
- W4368358565 cites W3174365407 @default.
- W4368358565 cites W3178066990 @default.
- W4368358565 cites W3194355129 @default.
- W4368358565 cites W3206010422 @default.
- W4368358565 cites W3209806877 @default.
- W4368358565 cites W3216510819 @default.
- W4368358565 cites W3217696142 @default.
- W4368358565 cites W4200228033 @default.
- W4368358565 cites W4206546573 @default.
- W4368358565 cites W4211027571 @default.
- W4368358565 cites W4213360563 @default.
- W4368358565 cites W4223515782 @default.
- W4368358565 cites W4224282976 @default.
- W4368358565 cites W4293511050 @default.
- W4368358565 cites W4294992918 @default.
- W4368358565 cites W4309323103 @default.
- W4368358565 cites W4316039521 @default.
- W4368358565 cites W4321376284 @default.
- W4368358565 doi "https://doi.org/10.1186/s13045-023-01442-4" @default.
- W4368358565 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37138326" @default.
- W4368358565 hasPublicationYear "2023" @default.
- W4368358565 type Work @default.
- W4368358565 citedByCount "0" @default.
- W4368358565 crossrefType "journal-article" @default.
- W4368358565 hasAuthorship W4368358565A5002318539 @default.
- W4368358565 hasAuthorship W4368358565A5016322661 @default.
- W4368358565 hasAuthorship W4368358565A5018406495 @default.
- W4368358565 hasAuthorship W4368358565A5024557025 @default.
- W4368358565 hasAuthorship W4368358565A5049277889 @default.
- W4368358565 hasAuthorship W4368358565A5057209439 @default.
- W4368358565 hasAuthorship W4368358565A5061440496 @default.
- W4368358565 hasAuthorship W4368358565A5078949281 @default.